What if...
We define cancer as a disease of evolutionary origin?
What if...
We accept that successful treatment of cancer will require dealing with ecology and evolution of tumors?
What if...
We can learn from mother Nature how it uses evolution to solve the biological problems and use this knowledge to develop entirely new class of drugs?
Aveta Biomics is pioneering a way to unlock the power of nature-inspired drugs. Our platform, powered by insights into evolutionary biology, creates the next generation of first-in-class immune-oncology drugs intended to provide a durable response to cancer patients.